GelMEDIX
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
238 Main St Ste 5, Cambridge, Massachuse...Website
www.gelmedix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About GelMEDIX
GelMEDIX is a biotechnology company developing regenerative therapies that restore vision by regenerating damaged retinal cells and preserving the essential structures required for sight. GelMEDIX programs are based on the company's proprietary injectable hydrogel scaffold technology platform, which is engineered to optimize the delivery, efficacy, and safety of cell and gene therapies. The company is focusing this platform on eye diseases that lack effective treatment options, with an initial focus on late-stage Geographic Atrophy (GA). In addition to developing a pipeline of next-generation regenerative therapies for ophthalmic diseases, GelMEDIX aims to optimize the potential of its regenerative medicine technology platform by forging partnerships to optimize cell and gene therapies for other degenerative disorders. GelMEDIX is based in the Kendall Square district of Cambridge, Massachusetts.Explore more
GelMEDIX Org Chart
PV
Data Scientist & Independent Contractor
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GelMEDIX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if GelMEDIX has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when GelMEDIX launches new products
GelMEDIX, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if GelMEDIX had a recent Job posting/layoffs
Earning: See what the market has to say on GelMEDIX recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at GelMEDIX
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once GelMEDIX has new funding data
Check out if GelMEDIX is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined GelMEDIX as Masked Content
Find 3 more new buyers
Compare Similar Companies to GelMEDIX
Compare insights from companies similar to GelMEDIX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GelMEDIX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GelMEDIX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GelMEDIX.
GelMEDIX financials insights
Gather financial insights about GelMEDIX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Seed
$13M
GelMEDIX Tech Stack
A closer look at the technologies used by GelMEDIX
GelMEDIX News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GelMEDIX
Sign Up For FreeTo access detailed company insights
GelMEDIX is a biotechnology company developing regenerative therapies that restore vision by regenerating damaged retinal cells and preserving the essential structures required for sight. GelMEDIX programs are based on the company's proprietary injectable hydrogel scaffold technology platform, which is engineered to optimize the delivery, efficacy,... Read More
